会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 28. 发明授权
    • Astrocyte-specific transcription of human genes
    • 人类基因的星形胶质细胞特异性转录
    • US5627047A
    • 1997-05-06
    • US197463
    • 1994-02-16
    • Michael BrennerFrancois BesnardYoshihiro Nakatani
    • Michael BrennerFrancois BesnardYoshihiro Nakatani
    • C07K14/47C12N15/85C12N15/10C12N15/62
    • C12N15/85C07K14/47C07K14/4711C12N15/8509A01K2217/05A01K2227/10A01K2267/03A01K2267/0318C12N2830/008C12N2830/85
    • Three unique control DNA sequences of the glial fibrillary acidic (gfa) protein gene have been identified upstream of its basal promoter that are capable of regulating astrocyte-specific transcription of the human gene for glial fibrillary acidic protein (GFAP). One or more of those three regions alone or together with the SV40 early promoter and SV40 enhancer control expression of endogenous or heterologous protein in astrocytes. Transgenic animals expressing amyloid protein can be prepared and used as a model for evaluating Alzheimer's disease. Many heterologous proteins can be expressed in the astrocytes so as to take advantage of the growing list of astrocyte functions. Such proteins include hormones, growth factors, and their receptors. Examples include basic fibroblast growth factor (bFGF), acidic FGF (aFGF), platelet derived growth factor (PDGF), insulin like growth factors 1 and 2 (IGF-1, IGF-2), epidermal growth factor (EGF), transforming growth factors .beta.-1 and .beta.-2 (TGF.beta.1, TGF.beta.2), and S100.beta.; other examples totalled proteins encoded by oncogenes like myc, fos, and erb-a, ion channels, like the calcium channel and the potassium channel, and metabolic enzymes, especially ones involved in processing drugs or neurotransmitters; e.g., glutamine synthetase. Additionally, in each case, a dominant dysfunctional protein, an antisense RNA, or a ribozyme, all of which can inhibit the function or production of the protein, can be expressed in astrocytes.
    • 已经在其基础启动子的上游鉴定了胶质纤维酸性(gfa)蛋白基因的三个独特的对照DNA序列,其能够调节神经胶质纤维酸性蛋白(GFAP)的人类基因的星形胶质细胞特异性转录。 这三个区域中的一个或多个单独或与SV40早期启动子和SV40增强子一起控制内源或异源蛋白质在星形胶质细胞中的表达。 可以制备表达淀粉样蛋白的转基因动物并用作评价阿尔茨海默病的模型。 许多异源蛋白质可以在星形胶质细胞中表达,以便利用增长的星形胶质细胞功能列表。 这些蛋白质包括激素,生长因子及其受体。 实例包括碱性成纤维细胞生长因子(bFGF),酸性FGF(aFGF),血小板衍生生长因子(PDGF),胰岛素样生长因子1和2(IGF-1,IGF-2),表皮生长因子(EGF) 因子β-1和β-2(TGFβ1,TGFβ2)和S100β; 其他实例总共由癌基因如myc,fos和erb-a编码的蛋白质,离子通道,如钙通道和钾通道,以及代谢酶,特别是涉及加工药物或神经递质的代谢酶; 例如谷氨酰胺合成酶。 此外,在每种情况下,可以在星形胶质细胞中表达所有可以抑制蛋白质的功能或产生的显性功能障碍蛋白质,反义RNA或核酶。
    • 29. 发明授权
    • Special effect apparatus with power control
    • 具有电源控制功能的特殊效果器
    • US5132798A
    • 1992-07-21
    • US624719
    • 1990-12-03
    • Katsuji YoshimuraYoshihiro NakataniTadayoshi Nakayama
    • Katsuji YoshimuraYoshihiro NakataniTadayoshi Nakayama
    • H04N5/225H04N5/262H04N5/265H04N5/77H04N5/92
    • H04N5/2621H04N5/265H04N5/77H04N5/9205Y10S358/906
    • A special effect device comprising a first signal source, a second signal source, subtracting circuit, coefficient multiplying circuit, adding circuit, switch circuit and control circuit. The subtracting circuit is arranged to produce a difference signal between the signals of the first signal source and the second signal source. The coefficient multiplying circuit multiplies the difference from the subtracting circuit by a predetermined coefficient and the adding circuit adds the signals output from the first and second signal sources to the signal output from the multiplying circuit. The switch circuit selectively outputs the output of the first signal source or an output of the adding circuit. The control circuit is arranged to stop the supply of power to at least the subtracting circuit when the switch circuit is selectively outputting the output of the first signal source.
    • 一种特效装置,包括第一信号源,第二信号源,减法电路,系数乘法电路,加法电路,开关电路和控制电路。 减法电路被布置成在第一信号源和第二信号源的信号之间产生差分信号。 系数乘法电路将来自减法电路的差值乘以预定系数,并且加法电路将从第一和第二信号源输出的信号与从乘法电路输出的信号相加。 开关电路选择性地输出第一信号源的输出或加法电路的输出。 控制电路被布置为当开关电路选择性地输出第一信号源的输出时,停止向至少减法电路的电力供应。